Publications, research & innovation
Research that informs policy-relevant decisions
Peer-reviewed research and international patents spanning clinical medicine, microbiome science, immunology, cannabinoid therapeutics and translational healthcare innovation.
Research areas
- Clinical medicine
- Microbiome science
- Immunology
- Cannabinoid therapeutics
- Nanoparticle drug delivery
- Oro-buccal delivery platforms
- Cancer-associated pain
- Translational innovation
Therapeutic delivery innovation
A key focus of Dr Hall's work has been the development and translation of novel therapeutic delivery systems, including advanced nanoparticle and oro-buccal platforms designed to improve bioavailability, dosing consistency and patient adherence.
These innovations support more effective management of complex conditions such as cancer-associated pain, inflammation and mental health burden, complementing primary clinical care.
Inventor & patent holder
As inventor on 47 patents globally across multiple healthcare technologies, Dr Hall has built intellectual property portfolios that bridge discovery science and real-world implementation, aligning innovation with regulatory standards, manufacturability and adoption pathways.
This experience underpins his advisory work for governments, regulators and healthcare organisations evaluating innovation adoption, translational readiness and long-term system impact.
Research impact summary
Why delivery science matters to health systems
~90%
of US national healthcare expenditure is attributed to chronic and co-morbid conditions.
50M+
US adults live with chronic pain, with annual economic costs estimated at $560–635 billion.
~55%
of US adults living with cancer report clinically significant pain, adding $4,000–5,000 in annual costs per patient.
$240B+
projected annual US cancer care costs by 2030, with survivorship and co-morbidity management a growing share.
Collectively, Dr Hall's research and innovation activities provide evidence-based insight into how healthcare innovation can be responsibly integrated into existing systems to address high-prevalence, high-cost conditions while maintaining safety, effectiveness and economic sustainability.
Research collaboration or peer review?
Enquiries from academic, clinical and industry partners are welcome.